289 related articles for article (PubMed ID: 31733339)
21. Clinical grading of intrahepatic cholestasis pregnancy.
Pradhan M; Shao Y
JNMA J Nepal Med Assoc; 2013; 52(190):413-9. PubMed ID: 24362672
[TBL] [Abstract][Full Text] [Related]
22. Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy.
Binder T; Salaj P; Zima T; Vítek L
J Perinat Med; 2006; 34(5):383-91. PubMed ID: 16965225
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy.
Parízek A; Simják P; Cerný A; Sestinová A; Zdenková A; Hill M; Dusková M; Vlk R; Kokrdová Z; Koucký M; Vítek L
Ann Hepatol; 2016; 15(5):757-61. PubMed ID: 27493115
[TBL] [Abstract][Full Text] [Related]
24. Ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy: a multi-centered randomized controlled trial.
Zhang L; Liu XH; Qi HB; Li Z; Fu XD; Chen L; Shao Y
Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3770-6. PubMed ID: 26502869
[TBL] [Abstract][Full Text] [Related]
25. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a secondary analysis of the PITCHES trial.
Fleminger J; Seed PT; Smith A; Juszczak E; Dixon PH; Chambers J; Dorling J; Williamson C; Thornton JG; Chappell LC
BJOG; 2021 May; 128(6):1066-1075. PubMed ID: 33063439
[TBL] [Abstract][Full Text] [Related]
26. Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy [see comemnts].
Brites D; Rodrigues CM
J Hepatol; 1998 Nov; 29(5):743-51. PubMed ID: 9833912
[TBL] [Abstract][Full Text] [Related]
27. Ursodeoxycholic acid therapy in intrahepatic cholestasis of pregnancy: Results in real-world conditions and factors predictive of response to treatment.
Bacq Y; le Besco M; Lecuyer AI; Gendrot C; Potin J; Andres CR; Aubourg A
Dig Liver Dis; 2017 Jan; 49(1):63-69. PubMed ID: 27825922
[TBL] [Abstract][Full Text] [Related]
28. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial.
Chappell LC; Bell JL; Smith A; Linsell L; Juszczak E; Dixon PH; Chambers J; Hunter R; Dorling J; Williamson C; Thornton JG;
Lancet; 2019 Sep; 394(10201):849-860. PubMed ID: 31378395
[TBL] [Abstract][Full Text] [Related]
29. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers.
Mazzella G; Rizzo N; Azzaroli F; Simoni P; Bovicelli L; Miracolo A; Simonazzi G; Colecchia A; Nigro G; Mwangemi C; Festi D; Roda E
Hepatology; 2001 Mar; 33(3):504-8. PubMed ID: 11230728
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis.
Bacq Y; Sentilhes L; Reyes HB; Glantz A; Kondrackiene J; Binder T; Nicastri PL; Locatelli A; Floreani A; Hernandez I; Di Martino V
Gastroenterology; 2012 Dec; 143(6):1492-501. PubMed ID: 22892336
[TBL] [Abstract][Full Text] [Related]
31. Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta.
Serrano MA; Brites D; Larena MG; Monte MJ; Bravo MP; Oliveira N; Marin JJ
J Hepatol; 1998 May; 28(5):829-39. PubMed ID: 9625319
[TBL] [Abstract][Full Text] [Related]
32. Intrahepatic cholestasis of pregnancy: Amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine.
Glantz A; Reilly SJ; Benthin L; Lammert F; Mattsson LA; Marschall HU
Hepatology; 2008 Feb; 47(2):544-51. PubMed ID: 17968976
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic and therapeutic profiles of serum bile acids in women with intrahepatic cholestasis of pregnancy-a pseudo-targeted metabolomics study.
Cui Y; Xu B; Zhang X; He Y; Shao Y; Ding M
Clin Chim Acta; 2018 Aug; 483():135-141. PubMed ID: 29709452
[TBL] [Abstract][Full Text] [Related]
34. Women successfully treated for severe intrahepatic cholestasis of pregnancy do not have increased risks for adverse perinatal outcomes.
Yang J; Chen C; Liu M; Zhang S
Medicine (Baltimore); 2019 Jul; 98(27):e16214. PubMed ID: 31277130
[TBL] [Abstract][Full Text] [Related]
35. Management of intrahepatic cholestasis of pregnancy.
Marschall HU
Expert Rev Gastroenterol Hepatol; 2015; 9(10):1273-9. PubMed ID: 26313609
[TBL] [Abstract][Full Text] [Related]
36. Society for Maternal-Fetal Medicine Consult Series #53: Intrahepatic cholestasis of pregnancy: Replaces Consult #13, April 2011.
; Lee RH; Mara Greenberg ; Metz TD; Pettker CM
Am J Obstet Gynecol; 2021 Feb; 224(2):B2-B9. PubMed ID: 33197417
[TBL] [Abstract][Full Text] [Related]
37. Bile acid profiles in intrahepatic cholestasis of pregnancy: is this the solution to the enigma of intrahepatic cholestasis of pregnancy?
Sinakos E; Lindor KD
Am J Gastroenterol; 2010 Mar; 105(3):596-8. PubMed ID: 20203641
[TBL] [Abstract][Full Text] [Related]
38. The concentrations of bile acids and erythropoietin in pregnant women with intrahepatic cholestasis and the state of the fetus and newborn.
Kowalska-Kańka A; Maciejewski T; Niemiec KT
Med Wieku Rozwoj; 2013; 17(3):232-45. PubMed ID: 24296447
[TBL] [Abstract][Full Text] [Related]
39. Gradual dosing of ursodeoxycholic acid in mothers with intrahepatic cholestasis of pregnancy may improve composite neonatal outcome.
Hamud A; Cohen MJ; Hochner-Celnikier D; Bar-Oz B; Ackerman Z
Ann Hepatol; 2024; 29(3):101490. PubMed ID: 38403070
[TBL] [Abstract][Full Text] [Related]
40. Ursodeoxycholic acid in the treatment of intraheptic cholestasis of pregnancy.
Liu Y; Qiao F; Liu H; Liu D
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(3):350-2. PubMed ID: 16961291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
